311 related articles for article (PubMed ID: 8085692)
21. Treatment of cutaneous T cell lymphoma: current status and future directions.
Apisarnthanarax N; Talpur R; Duvic M
Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
[TBL] [Abstract][Full Text] [Related]
22. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
23. Therapy of cutaneous lymphoma--current practice and future developments.
Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
[TBL] [Abstract][Full Text] [Related]
24. Mycosis fungoides and Sézary syndrome - Review and outlook.
Latzka J; Trautinger F
J Dtsch Dermatol Ges; 2023 Apr; 21(4):386-391. PubMed ID: 36971307
[TBL] [Abstract][Full Text] [Related]
25. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
[TBL] [Abstract][Full Text] [Related]
26. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
27. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
28. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
Stevens SR; Baron ED; Masten S; Cooper KD
Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
[TBL] [Abstract][Full Text] [Related]
29. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
[TBL] [Abstract][Full Text] [Related]
31. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
Akilov OE
Cells; 2023 Sep; 12(18):. PubMed ID: 37759543
[TBL] [Abstract][Full Text] [Related]
32. [Current therapeutic options in Mycosis fungoides and Sézary syndrome].
Albrecht JD; Nicolay JP
Hautarzt; 2022 Jan; 73(1):75-85. PubMed ID: 34988613
[TBL] [Abstract][Full Text] [Related]
33. How I treat mycosis fungoides and Sézary syndrome.
Whittaker S; Hoppe R; Prince HM
Blood; 2016 Jun; 127(25):3142-53. PubMed ID: 27151889
[TBL] [Abstract][Full Text] [Related]
34. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
Wu PA; Huang V; Bigby ME
Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
[TBL] [Abstract][Full Text] [Related]
35. The treatment of mycosis fungoides.
Mestel DS; Beyer M; Steinhoff M; Sterry W; Assaf C
G Ital Dermatol Venereol; 2008 Dec; 143(6):395-408. PubMed ID: 19169212
[TBL] [Abstract][Full Text] [Related]
36. Management of cutaneous T-cell lymphomas: Established and emergent therapies.
Wain T; Venning VL; Consuegra G; Fernandez-Peñas P; Wells J
Australas J Dermatol; 2019 Aug; 60(3):200-208. PubMed ID: 30809800
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
38. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
39. Management of refractory early-stage cutaneous T-cell lymphoma.
Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
[TBL] [Abstract][Full Text] [Related]
40. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
Photiou L; van der Weyden C; McCormack C; Miles Prince H
Curr Oncol Rep; 2018 Mar; 20(4):32. PubMed ID: 29572582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
